Company to host conference call and webcast at 8:30 a.m. Eastern Time NEW YORK, Aug. 5, 2025 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today that it will release its financial results for the 2nd quarter ended June 30th, 2025 and will host a conference call and webcast at 8:30 a.m. Eastern Time, on Tuesday, August 12th, 2025, before the market opens. Erez Raphael, Chief Executive Officer, Steven Nelson, President and ...

Core Insights - DarioHealth Corp. has presented new research demonstrating sustained outcomes for GLP-1 users and an 89% accuracy in AI-driven blood glucose predictions, indicating the company's strong position in the digital health market [1][2][6] Group 1: Research Findings - A significant reduction in eA1c levels from 9.0% to 6.7% was observed in GLP-1 users, with sustained results for six months post-medication discontinuation [2][8] - Users of Dario's platform maintained stable outcomes without significant weight or glucose rebound after stopping GLP-1 medication, addressing a critical challenge in chronic condition management [4][8] - The studies highlight the importance of integrated digital tools in enhancing medication adherence and optimizing health outcomes [5][6] Group 2: AI and Personalization - Dario's AI research achieved an 89% accuracy in predicting future blood glucose levels, utilizing user behavior and activity data [7][10] - The company's next-generation AI platform aims to provide personalized interventions based on real-time behaviors and clinical data, enhancing chronic condition management [6][9] - Age was identified as a significant factor influencing outcomes, with older adults showing stronger results through increased engagement in lifestyle activities [14] Group 3: Commercial Strategy - Dario is actively leveraging its research findings in discussions with payers and self-insured employers to offer integrated solutions for chronic condition management, particularly in GLP-1 optimization [3][10] - The company believes its platform can maximize return on investment for health plans and employers implementing GLP-1 programs, thereby enhancing commercial value [6][10]

Core Viewpoint - DarioHealth Corp. will release its financial results for the first quarter of 2025 on May 14, 2025, and will host a conference call to discuss these results [1][2]. Group 1: Conference Call Details - The conference call is scheduled for May 14, 2025, at 8:30 a.m. Eastern Time [3]. - Participants can join via a domestic dial-in number (1-800-717-1738) or an international number (1-646-307-1865) [3]. - A replay of the call will be available approximately two hours after the event until May 28, 2025 [3]. Group 2: Company Overview - DarioHealth Corp. is a leader in the digital health market, focusing on chronic condition management through a user-centric digital therapeutics platform [4]. - The platform provides personalized interventions for conditions such as diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health [4]. - DarioHealth's approach aims to empower users to make sustainable lifestyle changes, enhancing user satisfaction and retention [5]. Group 3: Market Reach - DarioHealth offers its solutions globally to health plans, self-insured employers, care providers, and consumers [6].

Company Leadership Transition - DarioHealth Corp. announced the retirement of Chief Financial Officer Zvi Ben-David, effective May 15, 2025 [1][2] - Chen Franco-Yehuda has been appointed as the new Chief Financial Officer, Treasurer, and Secretary, set to assume the role upon Mr. Ben-David's retirement [2][3] - Mr. Ben-David will assist the company in an advisory capacity until the end of June 2025 to ensure a smooth transition [2] New CFO's Background - Chen Franco-Yehuda brings extensive financial leadership experience, particularly in corporate finance, capital markets, and strategic growth initiatives [3] - She previously served as CFO at Pluri Inc., where she led financial strategy and secured substantial capital through various fundraising rounds [4] - Franco-Yehuda has a background as an Audit/Assurance Manager at PwC and is a licensed CPA in Israel [5] Company Growth and Strategy - Under Mr. Ben-David's leadership, DarioHealth transformed from a single-condition solution provider to a comprehensive multi-condition digital health platform [6] - The company has expanded its offerings across various health conditions, including diabetes, hypertension, mental health, weight management, and musculoskeletal care [6] - DarioHealth aims to leverage Franco-Yehuda's expertise to continue driving innovation and growth in the digital health sector [6][7]